Search Results

Feature

John P. Berdahl, MD

Interviewed by Callan Navitsky, Editor-in-Chief,
Glaucoma Today and MillennialEYE

Cover Focus

The Pipeline

Several groups are working to overcome challenges inherent to drop therapy.

By Morgan Fedorchak, PhD; Mark S. Humayun, MD, PhD; Molly M. Walsh, MD, MPH; and Tejal Desai, PhD

International Perspectives

Glaucoma Research in India

Although Indian ophthalmologists author many studies, the sheer volume of patients in the face of limited resources challenges most clinicians' ability to devote much time to research.

Subhabrata Chakrabarti, PhD, and Chandra S. Garudadri, MD

In Memoriam: 5 Questions With David L. Epstein, MD

Dr. Epstein stresses the need for MD clinician scientists and an interdisciplinary approach in glaucoma research.

In Memoriam: 5 Questions With David L. Epstein, MD

Dr. Epstein stresses the need for MD clinician scientists and an interdisciplinary approach in glaucoma research.

International Perspectives

International Glaucoma

A personal account of how collaborating with physicians overseas expands research possibilities.

Pradeep Y. Ramulu, MD, MHS, PhD

Schlemm Canal Surgery

Why you may not get the IOP low enough yet.

David L. Epstein, MD, MMM

Schlemm Canal Surgery

Why you may not get the IOP low enough yet.

David L. Epstein, MD, MMM

An Overview of Statins

How this class of drugs became of interest in glaucoma, and why research continues.

David L. Epstein, MD

5 Questions With David L. Epstein, MD

David L. Epstein, MD

5 Questions With David L. Epstein, MD

David L. Epstein, MD